Cargando…

Using variation between countries to estimate demand for Cochrane reviews when access is free: a cost–benefit analysis

OBJECTIVES: Cochrane reviews are currently of limited use as many healthcare professionals and patients have no access to them. Most member states of the Organisation for Economic Co-operation and Development (OECD) choose not to pay for nationwide access to the reviews, possibly uncertain whether t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobs, Perke, Gigerenzer, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314729/ https://www.ncbi.nlm.nih.gov/pubmed/34312188 http://dx.doi.org/10.1136/bmjopen-2019-033310

Ejemplares similares

Cross-country and panel data estimates of the price elasticity of demand for cigarettes in Europe
por: Kohler, Andreas, et al.
Publicado: (2023)

Calculated risks: how to know when numbers deceive you
por: Gigerenzer, Gerd
Publicado: (2003)

Distribution of Country of Origin in Studies Used in Cochrane Reviews
por: Wolff, Robert F., et al.
Publicado: (2011)

Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients
por: Federici, Carlo, et al.
Publicado: (2018)

Overweight and obesity on the island of Ireland: an estimation of costs
por: Dee, Anne, et al.
Publicado: (2015)

Cost–benefit analysis of surveillance for surgical site infection following caesarean section
por: Wloch, Catherine, et al.
Publicado: (2020)

Public Knowledge of Benefits of Breast and Prostate Cancer Screening in Europe
por: Gigerenzer, Gerd, et al.
Publicado: (2009)

Establishing reference costs for the health benefit packages under universal health coverage in India: cost of health services in India (CHSI) protocol
por: Prinja, Shankar, et al.
Publicado: (2020)

Benefit–cost analysis of electronic claims processing under Ghana’s National Health Insurance Scheme
por: Nonvignon, Justice, et al.
Publicado: (2022)

How much does it cost to combine supply-side and demand-side RBF approaches in a single intervention? Full cost analysis of the Results Based Financing for Maternal and Newborn Health Initiative in Malawi
por: Torbica, Aleksandra, et al.
Publicado: (2022)

Prevalence-based, disease-specific estimate of the social cost of smoking in Singapore
por: Cher, Boon Piang, et al.
Publicado: (2017)

What are the cost savings associated with providing access to specialist care through the Champlain BASE eConsult service? A costing evaluation
por: Liddy, Clare, et al.
Publicado: (2016)

A cost-benefit analysis of twice-daily consultant ward rounds and clinical input on investigation and pharmacy costs in a major teaching hospital in the UK
por: Ahmad, Aftab, et al.
Publicado: (2015)

Cochrane corner: community-level interventions to increase access to food in low- and middle-income countries
por: Durão, Solange, et al.
Publicado: (2022)

Analyzing the Costs and Benefits of Brief Intervention
por: Mundt, Marlon P.
Publicado: (2006)

The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke
por: van Eeden, M, et al.
Publicado: (2015)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

US gynecologists’ estimates and beliefs regarding ovarian cancer screening’s effectiveness 5 years after release of the PLCO evidence
por: Wegwarth, Odette, et al.
Publicado: (2018)

Effect of price and income on the demand for sugar-sweetened beverages in Nigeria: an analysis of household consumption data using an almost ideal demand system (AIDS)
por: Darsamo, Vanessa, et al.
Publicado: (2023)

Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007–2017
por: Huang, Shao-Yi, et al.
Publicado: (2020)

Estimating the costs of blindness and moderate to severe visual impairment among people with diabetes in India
por: Redding, Stuart, et al.
Publicado: (2023)

The economic benefit of hip replacement: a 5-year follow-up of costs and outcomes in the Exeter Primary Outcomes Study
por: Fordham, Richard, et al.
Publicado: (2012)

Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK
por: Becerra, Virginia, et al.
Publicado: (2015)

What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation
por: Thomas, Chloe, et al.
Publicado: (2020)

Cost and cost-effectiveness of point-of-care testing and treatment for sexually transmitted and genital infections in pregnancy in low-income and middle-income countries: a systematic review protocol
por: Saweri, Olga PM, et al.
Publicado: (2019)

Role of healthcare cost accounting in pricing and reimbursement in low-income and middle-income countries: a scoping review
por: Guinness, Lorna, et al.
Publicado: (2022)

Cost estimator's reference manual
por: Johannes, James D, et al.
Publicado: (1995)

Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls
por: Aebersold, Helena, et al.
Publicado: (2023)

Data to estimate costs of producing grass-clover silages
por: Flaten, Ola, et al.
Publicado: (2020)

Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study
por: Schofield, D., et al.
Publicado: (2020)

Randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website: cost-effectiveness analysis
por: Hunter, Rachael, et al.
Publicado: (2017)

Impact of conditional cash transfer programmes on antenatal care service uptake in low and middle-income countries: a systematic review
por: Jacobs, Ward, et al.
Publicado: (2022)

Cochrane corner: home or office when treating convergence insufficiency
por: Rowe, Fiona J., et al.
Publicado: (2021)

In primary care, is measuring free-thyroxine plus thyroid-stimulating hormone to detect hypopituitarism cost-effective? A cost utility analysis using Markov chain models
por: Shine, Brian, et al.
Publicado: (2019)

Estimating the cost-effectiveness and return on investment of the Victorian Cardiac Outcomes Registry in Australia: a minimum threshold analysis
por: Lee, Peter, et al.
Publicado: (2023)

Early offering transcatheter aortic valve replacement to patients with moderate aortic stenosis: quantifying costs and benefits – a Markov model-based simulation study
por: Nguyen, Dieu, et al.
Publicado: (2023)

A two-part model to estimate inpatient, outpatient, prescribing and care home costs associated with atrial fibrillation in Scotland
por: Ciminata, Giorgio, et al.
Publicado: (2020)

Cost-effectiveness of anatomical and functional test strategies for stable chest pain: public health perspective from a middle-income country
por: Bertoldi, Eduardo G, et al.
Publicado: (2017)

Investing in science: social cost-benefit analysis of research infrastructures
por: Florio, Massimo
Publicado: (2019)

Big research costs big money: are there also economic benefits?
por: Schmied, H, et al.
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_kt5i6eu1l3oesaru9r6lut7epi